APPLICATION
ANDA216128
TYPE
ANDA
ORIGINAL APPROVAL
2022-11-15
LATEST ACTION
2024-07-05
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ARFORMOTEROL TARTRATEPrescription
ARFORMOTEROL TARTRATE EQ 0.015MG BASE/2ML · SOLUTION · INHALATION
Approval history
2024-07-05Manufacturing (CMC) · Supplement 4 · unknownAP
2022-11-15UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.